{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T07:09:54Z","timestamp":1778137794100,"version":"3.51.4"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Direct"],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Multiple studies have failed to reveal an effective method for preventing the recurrence of primary sclerosing cholangitis (PSC) after liver transplantation (LTx). A national study conducted in Japan revealed several risk factors for the recurrence after living donor LTx (LDLTx); however, recipients of ABO-blood type incompatible (ABO-I) LTx were excluded from the previous analysis. In the present study, we investigated the efficacy of an immunosuppressive protocol in ABO-I LTx on the recurrence of PSC after LDLTx.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a national survey and analyzed the outcome of recipients who underwent ABO-I LDLTx for PSC (n = 12) between 1994 and 2010 in 9 centers and compared the outcome with that of ABO-compatible LDLTx for PSC (n = 96). The key elements of the immunosuppressive regimen in ABO-I LTx are plasma exchange sessions to remove existing antibodies, and the use of immunosuppression to control humoral immunity. Rituximab was added to the immunosuppression regimen from 2006 onward; 5 patients received rituximab perioperatively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>All 7 recipients who underwent ABO-I LDLTx before 2006 (who did not receive rituximab) died of infection (n = 3), antibody-mediated rejection (n = 1), ABO-incompatibility associated cholangiopathy (n = 1) or recurrence of PSC (n = 2). In contrast, we found that all 5 recipients from 2006 (who were treated with rituximab) retained an excellent graft function for more than 7 years without any recurrence of PSC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The findings of this study shed light on the efficacy of a novel strategy to prevent the recurrence of PSC and the possible mechanisms provided by rituximab treatment are discussed.<\/jats:p><\/jats:sec>","DOI":"10.1097\/txd.0000000000000760","type":"journal-article","created":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T17:31:35Z","timestamp":1516815095000},"page":"e342","source":"Crossref","is-referenced-by-count":17,"title":["Rituximab Induction to Prevent the Recurrence of PSC After Liver Transplantation\u2014The Lessons Learned From ABO-Incompatible Living Donor Liver Transplantation"],"prefix":"10.1097","volume":"4","author":[{"given":"Yohei","family":"Yamada","sequence":"first","affiliation":[{"name":"Department of Pediatric Surgery, Keio University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Hoshino","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, Keio University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Fuchimoto","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, Keio University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Matsubara","sequence":"additional","affiliation":[{"name":"Department of Surgery, Keio University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taizo","family":"Hibi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Keio University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yagi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Keio University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Surgery, Keio University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Shinoda","sequence":"additional","affiliation":[{"name":"Department of Surgery, Keio University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Kitago","sequence":"additional","affiliation":[{"name":"Department of Surgery, Keio University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Obara","sequence":"additional","affiliation":[{"name":"Department of Surgery, Keio University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahito","family":"Yagi","sequence":"additional","affiliation":[{"name":"Hepato-Biliary and Pancreatic Surgery, Okayama University Hospital, Okayama, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Okajima","sequence":"additional","affiliation":[{"name":"Division of Hepato-Biliary-Pancreatic Surgery and Transplant Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimi","family":"Kaido","sequence":"additional","affiliation":[{"name":"Division of Hepato-Biliary-Pancreatic Surgery and Transplant Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Uemoto","sequence":"additional","affiliation":[{"name":"Division of Hepato-Biliary-Pancreatic Surgery and Transplant Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, Fujita Health University School of Medicine, Toyoake, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Kubota","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Dokkyo Medical University, Tochigi, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoharu","family":"Yoshizumi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Maehara","sequence":"additional","affiliation":[{"name":"Department of Surgery, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Inomata","sequence":"additional","affiliation":[{"name":"Transplantation and Pediatric Surgery, Kumamoto University, Kumamoto, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Kitagawa","sequence":"additional","affiliation":[{"name":"Department of Surgery, Keio University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroto","family":"Egawa","sequence":"additional","affiliation":[{"name":"Department of Surgery, Institute of Gastroenterology, Tokyo Women\u2019s Medical University, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Kuroda","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, Keio University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2018,2]]},"reference":[{"key":"bib1-20231002","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/lt.24350","article-title":"Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: a retrospective multicenter analysis","volume":"22","year":"2016","journal-title":"Liver Transpl"},{"key":"bib2-20231002","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jhep.2015.07.005","article-title":"Risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"bib3-20231002","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-6143.2010.03402.x","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation in Japanese registry","volume":"11","year":"2011","journal-title":"Am J Transplant"},{"key":"bib4-20231002","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/lt.24380","article-title":"Can we avoid primary sclerosing cholangitis recurrence?","volume":"22","year":"2016","journal-title":"Liver Transpl"},{"key":"bib5-20231002","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1111\/ajt.13828","article-title":"First-degree living-related donor liver transplantation in autoimmune liver diseases","volume":"16","year":"2016","journal-title":"Am J Transplant"},{"key":"bib6-20231002","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.21679","article-title":"A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts","volume":"15","year":"2009","journal-title":"Liver Transpl"},{"key":"bib7-20231002","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/bjs.10048","article-title":"Case-matched comparison of ABO-incompatible and ABO-compatible living donor liver transplantation","volume":"103","year":"2016","journal-title":"Br J Surg"},{"key":"bib8-20231002","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/hep.510290427","article-title":"Recurrence of primary sclerosing cholangitis following liver transplantation","volume":"29","year":"1999","journal-title":"Hepatology"},{"key":"bib9-20231002","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jhep.2014.04.039","article-title":"Biliary stricture is the only concern in ABO-incompatible adult living donor liver transplantation in the rituximab era","volume":"61","year":"2014","journal-title":"J Hepatol"},{"key":"bib10-20231002","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/ajt.12520","article-title":"Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study","volume":"14","year":"2014","journal-title":"Am J Transplant"},{"key":"bib11-20231002","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hep.21928","article-title":"Present status of ABO-incompatible living donor liver transplantation in Japan","volume":"47","year":"2008","journal-title":"Hepatology"},{"key":"bib12-20231002","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/ndt\/gfw017","article-title":"The effect of rituximab dose on infectious complications in ABO-incompatible kidney transplantation","volume":"31","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 8","key":"bib13-20231002","first-page":"S59","article-title":"Section 15. A desensitizing protocol without local graft infusion therapy and splenectomy is a safe and effective method in ABO-incompatible adult LDLT","volume":"97","year":"2014","journal-title":"Transplantation"},{"key":"bib14-20231002","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/ajt.13444","article-title":"ABO-incompatible adult living donor liver transplantation under the desensitization protocol with rituximab","volume":"16","year":"2016","journal-title":"Am J Transplant"},{"key":"bib15-20231002","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00534-007-1298-2","article-title":"Current status of liver transplantation across ABO blood-type barrier","volume":"15","year":"2008","journal-title":"J Hepatobiliary Pancreat Surg"},{"issue":"Suppl 3","key":"bib16-20231002","first-page":"S463","article-title":"Histological recurrence of autoimmune liver diseases after living-donor liver transplantation","volume":"37","year":"2007","journal-title":"Hepatol Res"},{"key":"bib17-20231002","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/2040622315605821","article-title":"A review of the medical treatment of primary sclerosing cholangitis in the 21st century","volume":"7","year":"2016","journal-title":"Ther Adv Chronic Dis"},{"key":"bib18-20231002","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/MEG.0000000000000596","article-title":"Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options","volume":"28","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"bib19-20231002","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1586\/egh.12.58","article-title":"Serum autoantibodies for the diagnosis and management of autoimmune liver diseases","volume":"6","year":"2012","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"bib20-20231002","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/gut.51.1.120","article-title":"High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6","volume":"51","year":"2002","journal-title":"Gut"},{"key":"bib21-20231002","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2007.01.039","article-title":"Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis","volume":"132","year":"2007","journal-title":"Gastroenterology"},{"key":"bib22-20231002","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00535-016-1163-7","article-title":"IgG4-related sclerosing cholangitis: all we need to know","volume":"51","year":"2016","journal-title":"J Gastroenterol"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01845228-201802000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:24:18Z","timestamp":1751243058000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01845228-201802000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":22,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000000760","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2]]}}}